WitrynaImmatics 12.823 Follower:innen auf LinkedIn. Delivering the Power of T Cells to Cancer Patients Immatics combines the discovery of true targets for cancer … Witryna1 Immatics Biotechnologies GmbH, Tübingen, Germany. 2 BioNTech AG, Mainz, Germany. 3 Eberhard Karls Universität Tübingen, Tübingen, Germany. 4 German Cancer Consortium (DKTK), German Cancer Research Center Partner Site Tübingen, Tübingen, Germany.
Kathy-Ann SECKER Scientist Doctor of Pharmacy Immatics ...
WitrynaImmatics Biotechnologies GmbH. Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany. Phone: +49 7071 5397-0, Fax: +49 7071 5397-900 E-Mail: [email protected] Witryna26 maj 2024 · Tübingen, Deutschland und Houston, Texas, 26.Mai, 2024 – Immatics N.V. (NASDAQ: IMTX, „Immatics”) ein Unternehmen, das sich auf die Entwicklung und Herstellung von T-Zell-Immuntherapien für die Behandlung von Krebs fokussiert, gab heute personelle Veränderung seines Aufsichtsrats bekannt. Christof Hettich, L.L.D., … photographer rose bay
Investors & Media Immatics N.V.
Witryna2000 Co-founder of the biotechnology enterprises immatics GmbH and CureVac GmbH. 1996 – present Chair, Department of Immunology (Full Professor, C4), Interfaculty Institute for Cell Biology, University of Tübingen, Germany ... 1993 Academic teaching duties at the Universities of Tübingen and Heidelberg. 1987 – 1993 Group leader at … WitrynaToni WEINSCHENK Cited by 5,355 of Immatics Biotechnologies, Tübingen Read 106 publications Contact Toni WEINSCHENK WitrynaProf Hans-Georg Rammensee studied biology at Eberhard Karls University Tuebingen. He completed his Ph.D. at the Max-Planck-Institute in Tuebingen in the group of Prof … photographer sharing site